Armistice Capital »

Briacell Therapeutics Corp shares owned by Armistice Capital

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTXW) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $510k 375k 1.36
2023-09-30 $926k 375k 2.47
2023-06-30 $938k 375k 2.50
2023-03-31 $1.1M 375k 2.96
2022-12-31 $773k 375k 2.06
2022-09-30 $1.1M 375k 2.87
2022-03-31 $2.0M 375k 5.20
2021-12-31 $1.8M 375k 4.69
2021-09-30 $1.8M 375k 4.75
2021-06-30 $675k 375k 1.80
2021-03-31 $450k 421k 1.07

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Briacell Therapeutics Corp

Armistice Capital
Redmond Asset Management
Advisor Group Holdings

View all funds holding Briacell Therapeutics Corp